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EDITORIAL

Quality in CKD: The 3 ‘‘Cs’’

I

n this issue of Advances in Chronic Kidney Disease, we
find its essence in the cover illustration—an idealized,
but not unrealistic, interdigitating conceptualization of
the multiplicity of interactions of clinical CKD care
between nephrologist and primary care physician
(PCP), with the patient juxtaposed between them. The
Co-Editors of this issue, Drs. Rebecca J. Schmidt and
Bethany S. Pellegrino, in conjunction with their contributing authors, present a series of papers that portrays the
colors of CKD that continually confront and challenge
PCPs and kidney physicians in their efforts to
deliver quality care. But,
what is the formula for
ensuring the quality of
CKD care?
‘‘Quality doesn’t cost,
it pays’’ is the slogan
that is splashed across
my housepainter’s truck.
He’s right, and the secret
to improving the quality
of care in CKD, improving efficiency and reducing costs, is within the
CKD acronym itself. The
‘‘C’’ of CKD may first be
considered as ‘‘capturing’’ kidney disease.
Correspondingly, spirited and vigorous educational efforts have been and must still be focused on
empowering PCPs to ascertain when CKD is present.
The NKF’s eGFR equations have accomplished this
and in a large way. Presently, nearly 90% of United
States clinical laboratories yield an eGFR from serum
creatinine values. However, what proportion of PCPs
can correctly explain the concept of eGFR to their patients? My own experience, and that of others, reveals
that the proportion is highly variable and a direct

function, in large part, of the degree of eGFR education
imparted to PCPs and the follow-up and reinforcement
of that education. Clearly some institutions have made
it a priority to educate physicians and nurses regarding
this CKD-capturing tool and others have not. Producing
an eGFR strategy is not the problem, but implementing
a sound educational program around it is. One other
problem in the interpretation is the various formulas
for eGFR that may be confusing to PCPs and nephrologists alike.
Furthermore, has
a mantra for capturing kidney disease
pervaded all institutions? Hardly, as
hypertension, heart
failure, stroke, diabetes, arthritis, cancer,
and asthma have assumed preeminent
importance at many
institutions as core
disorders on which
many programmatic
developmental dollars have been allocated. Distressingly,
CKD is only considered an expense generator when the bills
come in, despite that
CKD is part and parcel of many of these core disease
states. Until patients at risk for CKD are screened appropriately for eGFR, especially in association with albuminuria, obstruction, and acute kidney injury, the capture rate
will remain suboptimal. Here, nephrologists must clearly
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assume leadership and recognize that despite rigorous
and disciplined educational efforts at the national level,
success at the individual point-of-service level represents
the appropriate established benchmark and true challenge.
To effect and sustain quality, the second ‘‘C’’ of CKD
must be considered ‘‘collaborative,’’ as espoused in the
Guest Editorial, especially because there are typically several health care providers per CKD patient. Collaborative
care will be vital to the initiation and maintenance of the
CKD advanced medical home, with the nephrologist as
neighbor. Likewise, if accountable care organizations
come to the fore, collaboration will be the linchpin of
the relationships among physicians participating in the
care of CKD and beyond.1 Therefore, physician alignment
is incumbent for programmatic CKD success. Correspondingly, the increasing trend toward full employment
staffing models of hospitals and health systems may be
the first step in the process. A recent survey acknowledged that 70% of hospital and health care respondents
intended to gravitate to a full staff model, a significant
increase from ,50% several years ago.2 Caution must be
exerted though, as simply putting physicians together
under a single banner does not increase engagement
pari passu. Effective and broadly based engagement strategies are implicit to goals’ attainment over the long-term,
and the ‘‘overriding goal of a physician employment strategy needs to focus on quality.’’2 Moreover, requirements
for collaboration and synergy are not limited to intersections between primary care and nephrology, but are also
intrinsic to interactions between clinicians, including
other subspecialists and allied health care professionals,
and clinical laboratories.
Directed care as part of the collaborative process must
be learned and embraced by nephrologists. Neither the
nephrologist nor PCP should anticipate shepherding the
CKD patient through all stages of the disease. The PCP
and nephrologist are chiral partners: each has an overlapping, but not exactly similar, skill set. Nephrologists must
abandon the classical referral-based model, and Medicare
already has. Composing a nicely worded letter back to
a referring physician with multiple recommendations
ensures neither their implementation nor the high fidelity
processing of trend analysis that each CKD parameter
deserves. Brief summaries of important findings and concise, precise, and definitive recommendations are preferred over the classical model. The latter is ‘‘better’’
than that which is conventionally practiced, but ‘‘best’’
when the nephrologist enacts his own recommendations
and collaboratively implements a longitudinal CKD
action plan in partnership with a PCP.
Immediate communication back to the PCP is indispensable in the conduct of directed care, as professional
collegiality and colloquy remain logistical cornerstones
of nephrologist-directed care.3 However, in large health
organizations, institution of directed care by subspecial-

ists should be thoroughly discussed among all interested
and impacted parties. With the hope of improving timeliness of referral of advancing CKD patients to nephrologists, it is notable that this goal has not been achieved,
even within benchmark organizations.4 Locally generated
educational and evidence-based materials may prompt
in-house engagement and must be distributed widely to
nursing staff, midlevel providers, and physicians in training.5 Within the realm of CKD, the data of Curtis and
colleagues clearly demonstrated that their deployment
of multidisciplinary directed care correlated with improved outcomes for patients who progressed to ESRD.6
The third ‘‘C’’ of CKD is computerization, and this must
be established throughout the continuum of care. Speedy,
efficient, and automated CKD patient database generation
eases the capture of CKD patients. Risk stratification can
also be automated and conveniently reported. An exemplar of such a strategy was recently described at the Cleveland Clinic.7 Given that the American Recovery and
Reinvestment Act’s subsidiary incentivized Health Information Technology for Economic and Clinical Health
Act8,9 has established minimal standards within the
context of ‘‘improving health care quality, safety, and
efficiency,’’ one cannot argue that data and biomedical
and health informatics are inessential or avoidable in the
proactive operationalization of CKD action plans.
Efficacious care entails knowledge of business principles
and the will and skill to carry these out. A prototypical
Six Sigma-type approach like this fully lends itself to the
complex care of CKD patients and can retain the art of doing so. Therefore, defining processes of care, measuring
their output, analyzing the results, improving on them,
and controlling patient outcomes are obligatory.10 The automation of processes to this end is mandatory to achieve
‘‘meaningful use.’’8
In areas that do not possess a sufficient clinical evidence
base to establish definitive practice guidelines, automated
information gathering is critical. Furthermore, an overlaying of natural language processing and other sophisticated techniques can render novel insights and potential
solutions to problems that heretofore were equated as
insoluble.11 Finally, a supplementary benefit of CKD computerization is hypothesis generation for comparative
effectiveness research, whereby large populations may
be, in unadjusted manner, retrospectively probed for
positive determinants of CKD care as well as adherence
to such determinants.12 Consequently, we can no longer
consider the aforementioned electronic health record
applications as ‘‘secondary’’ uses or ‘‘re-uses’’ but as
‘‘primary’’ uses.12,13 An outstanding benefit of skilled
deployment of CKD computerization is that it potentially
informs existing and nonexistent computerized order
entry systems while it allows practice assessment and
facilitates quality improvement.
Capturing CKD, collaborating with stakeholders of
CKD, and embedding computerization into CKD processes
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to improve the quality of CKD care and its outcomes are underway. Local, state, and national funding of the initial associated financial distresses incurred from operationalizing
CKD processes is a proviso and must be fought for. In parallel, physicians—notoriously slow ‘‘change’’ agents—who
take up to 17 years to fully implement a published guideline must be compelled to carry out the ‘‘3 Cs’’ of CKD in
concert and discharge them effectively, to overcome therapeutic inertia and to gain the momentum necessary to advance the quality of care in CKD.14
Finally, to underscore the NKF’s efforts to cooperatively
combat CKD, the organization’s President, Dr. Lynda
Szczech, has reached out to PCPs to participate in a multisite cross-sectional study that estimates the prevalence of
CKD in type 2 diabetic adults. In the study ‘‘Awareness,
Detection and Drug Therapy in Type 2 Diabetes Mellitus
and Chronic Kidney Disease’’ (study description available
at: http://www.kidney.org/ADD-CKD), PCPs will enroll
patients, obtain specific blood and urine tests, and retrospectively determine whether CKD was captured within
the health record as a problem, diagnosis, and so on.
This information will potentially provide a more facile
comprehension of current CKD screening and health
care utilization in a high-risk population, thereby facilitating future improved development of NKF educational efforts for all CKD care providers and patients.
Jerry Yee, MD
Editor
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